About Contact Us Careers
Sign In

Prognostic Biomarkers Market - Top Companies and Manufacturers

  • Report ID: 3091
  • Published Date: Sep 03, 2024
  • Report Format: PDF, PPT

Companies Dominating the Prognostic Biomarkers Landscape

    • Meso Scale Diagnostics, LLC
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • PerkinElmer Inc.
    • Myriad Genetics, Inc.
    • Siemens Healthcare GmbH
    • F. Hoffmann-La Roche Ltd
    • Epigenomics AG
    • Thermo Fisher Scientific Inc.
    • Bio-Rad Laboratories, Inc.
    • QIAGEN GmbH
    • Biomarker Technologies, Inc.
Browse Key Market Insights with Data Illustration:

In the News


Author Credits:  Radhika Pawar


  • Report ID: 3091
  • Published Date: Sep 03, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Prognostic Biomarkers Market size is poised to witness lucrative growth rate during the forecast period i.e., between 2024-2036.

Rising cases of chronic disease recurrence will impel the market growth.

North America is expected to hold largest revenue share by 2036, on the back of increasing health awareness among people, along with high per capita healthcare expenditure by the government.

The major players in the market are PerkinElmer Inc., Myriad Genetics, Inc., Siemens Healthcare GmbH, F. Hoffmann-La Roche Ltd, Epigenomics AG, Thermo Fisher Scientific Inc., and others.
Inquiry Before Buying Request Free Sample

Copyright © 2024 Research Nester. All Rights Reserved

logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample